Posts by rw-admin
CubeSmart Announces Pricing of 5.125% Senior Unsecured Notes Due 2035
Vinson and Elkins acted as underwriters’ counsel in CubeSmart, L.P.’s public offering of $450,000,000 of 5.125% senior unsecured notes due 2035.
Read MoreKirkland Advises Thoma Bravo on $12.3 Billion Definitive Agreement to Take Dayforce Private
Kirkland & Ellis represented Thoma Bravo, a leading software investment firm, in a definitive $12.3 billion take-private agreement with Dayforce, Inc. (NYSE:DAY) (TSX:DAY).
Read MoreWhite & Case advises Saudi Aramco on landmark US$11 billion Jafurah midstream deal
White & Case LLP represented Saudi Aramco in a US$11 billion lease and leaseback deal, involving its Jafurah gas processing facilities, with a consortium of international investors led by funds managed by Global Infrastructure Partners (GIP).
Read MoreWillkie Advises Special Committee of Guess? Board of Directors in $1.4 Billion Take-Private Acquisition
Willkie Farr & Gallagher LLP acted for the Special Committee of the Board of Directors of Guess?, Inc. (NYSE: GES) in the take-private acquisition of Guess? by certain shareholders in partnership with Authentic Brands Group.
Read MoreGuess? co-founders Maurice and Paul Marciano and CEO Carlos Alberini Partner with Authentic Brands Group to take Guess? private
Jones Day is representing the co-founders and Chief Executive Officer of Guess?, Inc. (NYSE: GES) in their strategic partnership with Authentic Brands Group LLC. Under the partnership, Authentic will acquire 51% of substantially all Guess? intellectual property and all of the outstanding common stock of Guess? not owned by the rolling stockholders.
Read MoreFoley Represents LM Funding America in $23M Capital Raise
Foley & Lardner LLP acted for LM Funding America, Inc., a Bitcoin treasury and mining company, in its $23 million capital raise through a combination of a $12.6 million registered direct offering and a $10.4 million private placement.
Read MoreDechert Advises Aquestive Therapeutics on Two Transactions to Assist in Launch of Anaphylm Sublingual Film
Dechert represented Aquestive Therapeutics Inc. in two transactions aimed at advancing the launch and commercialization of Anaphylm Sublingual Film, a polymer matrix-based epinephrine prodrug designed as a rescue treatment for severe allergic reactions including anaphylaxis.
Read MoreEssential Utilities, Inc.’s Senior Notes Offering
Cravath, Swaine & Moore LLP acted for the underwriters in the $500 million senior notes offering of Essential Utilities, Inc., a holding company for regulated utilities providing water, wastewater or natural gas services to an estimated 5.5 million people in Pennsylvania, Ohio, Texas, Illinois, North Carolina, New Jersey, Indiana, Virginia and Kentucky under the Aqua…
Read MoreEpic Games’ Ninth Circuit Win Affirming Antitrust Trial Victory and Permanent Injunction Against Google
Cravath, Swaine & Moore successfully represented Epic in an antitrust lawsuit against Google in the U.S. District Court for the Northern District of California. The court affirmed a jury verdict that Google has engaged in illegal anticompetitive behavior in the distribution of mobile apps and in the handling of in‑app payments.
Read MoreGrant Thornton Advisors LLC Further Expands Advisory Platform Through Acquisition of Stax LLC
Simpson Thacher is acting for Grant Thornton Advisors LLC and funds managed by New Mountain Capital LLC in connection with Grant Thornton Advisors’ acquisition of Stax LLC, a strategy consulting firm.
Read More